Zoledronic acid to prevent skeletal complications in cancer: Corroborating the evidence
To access this article, please choose from the options below
PII: S0305-7372(05)00163-5
doi:10.1016/j.ctrv.2005.09.004
© 2005 Elsevier Ltd. All rights reserved.
PII: S0305-7372(05)00163-5
doi:10.1016/j.ctrv.2005.09.004
© 2005 Elsevier Ltd. All rights reserved.